← Back
$ROIV All transactions

Roivant Sciences Ltd.

A

$ Value

$0

Shares

27,157

Price

$0

Filed

Apr 22

Insider

Name

Humes Jennifer

Title

Chief Accounting Officer

CIK

0002058012

Roles

Officer

Transaction Details

Transaction Date

2026-04-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

27,157

Footnotes

Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2026. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through each applicable vesting date. | Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2026. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through each applicable vesting date.

Filing Info

Accession No.

0001635088-26-000042

Form Type

4

Issuer CIK

0001635088

Humes Jennifer's History

Date Ticker Type Value
2026-04-20 ROIV A $0
2026-04-20 ROIV A $0
2026-04-08 ROIV $384K
2026-03-20 ROIV F $402K

Other Insiders at ROIV (90d)

Insider Bought Sold Last
MOMTAZEE JAMES C 2026-04-17
Fitzgerald Meghan $1.9M 2026-03-26
Oren Ilan 2026-04-17
Torti Frank
President and Vant Chair
2026-03-31
Sukhatme Mayukh
President & CIO
2026-03-31
Gline Matthew
CEO
$8.4M 2026-04-16
Venker Eric
President & Immunovant CEO
$5.9M 2026-04-20
Epperly Melissa B, 2026-04-17
Pulik Richard
CFO
2026-04-20
Humes Jennifer
Chief Accounting Officer
$384K 2026-04-20